TSX News -
Nuvei Corporation Announces Pricing of Initial Public Offering
MONTREAL, Sept. 16, 2020 (GLOBE NEWSWIRE) — Nuvei Corporation (“Nuvei” or the “Company”) announced today that it has obtained a […]
Macarthur signs agreement with Canaria Technologies on cutting-edge safety technology
VANCOUVER, British Columbia, Sept. 17, 2020 (GLOBE NEWSWIRE) — Macarthur Minerals Limited (ASX: MIO) (TSX-V: MMS) (OTCQB: MMSDF) (the “Company” […]
Macarthur’s Pilbara gold and lithium tenements Earn-in Agreement with Fe Limited, comes to an end
VANCOUVER, British Columbia, Sept. 17, 2020 (GLOBE NEWSWIRE) — Macarthur Minerals Limited (ASX: MIO) (TSX-V: MMS) (OTCQB: MMSDF) (the “Company” […]
Lift & Co. Corp. Makes Voluntary Assignment into Bankruptcy Under the Bankruptcy and Insolvency Act (Canada) after Failing to Reach Agreement With Secured Creditors to Proposed Sale of Marketing Division
TORONTO, Sept. 16, 2020 (GLOBE NEWSWIRE) — Lift & Co. Corp. (TSXV:LIFT) (OTCQB:LFCOF) (“Lift & Co.” or the “Corporation”) announced […]
Forterra Announces Pricing of Secondary Offering of 10,000,000 Shares
IRVING, Texas, Sept. 16, 2020 (GLOBE NEWSWIRE) — Forterra, Inc. (the “Company” or “Forterra”) (NASDAQ: FRTA) announced today the pricing […]
Strongbridge Biopharma plc Announces Pricing of Public Offering of Ordinary Shares
DUBLIN, Ireland and TREVOSE, Pa., Sept. 16, 2020 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical […]
Golden Birch Announces Status of Keveri Option Party
TIMMINS, Ontario, Sept. 16, 2020 (GLOBE NEWSWIRE) — Golden Birch Resources Inc. (GBRX:CSE) (“Golden Birch” or the “Company”) wishes to […]
Sumo Logic Announces Pricing of Initial Public Offering
REDWOOD CITY, Calif., Sept. 16, 2020 (GLOBE NEWSWIRE) — Sumo Logic, Inc. (“Sumo Logic”) today announced the pricing of its […]
Target Capital Announces Director Changes
CALGARY, Alberta, Sept. 16, 2020 (GLOBE NEWSWIRE) — Target Capital Inc. d.b.a. CBi2 Capital (“CBi2” or the “Company”) is pleased […]
Sorrento Receives US FDA Clearance to Proceed With Phase 1 Clinical Trial of STI-1499 (COVI-GUARD) Neutralizing Antibody in COVID-19 Positive Patients
Phase 1 clinical trial for STI-1499 (COVI-GUARD™) in hospitalized COVID-19 patients has received FDA notice that it may proceed with […]
